A multicentre observational study on the practise of non invasive ventilation in COVID-19 patients with De novo acute hypoxemic respiratory failure and utilising HACOR scale to predict failure - MONICA

DR Saurav Sutradhar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•All the patients 18 years & above of age, suspected or tested positive for SARS-COV2 (RtPCR/RAT) being admitted to the
•Intensive care with de novo acute hypoxemic respiratory failure defined as recent onset respiratory failure as evidenced by a P/F
•ratio of less than equal to 300 mmHg, signs of respiratory distress along with the
•presence of pulmonary infiltrates on chest images, in the absence
•of chronic cardio-respiratory diseases, including extubation failure with hypoxemia and, in whom NiV was initiated and administered
•for at least 30 minutes. The underlying condition deemed to have caused DNAHRF and the reason for NiV initiation was adjudged
•by the treating Critical care physician and documented. ARDS will be diagnosed as per the BERLIN criteria.

•All patients with history of chronic cardio-respiratory illness as well as those who are home O2/Niv user.
•Patients who have failed extubation as well as those refusing NiV due to intolerance or with do not intubate orders.

发起方

DR Saurav Sutradhar